CPHI [CHINA PHARMA] DEF 14A: (Original Filing)
[]
CPHI [CHINA PHARMA] 8-K: (Original Filing)
[Contact: China Pharma Holdings, Inc. Ms. Diana Na Huang Phone: +86-898-6681-1730 (China) Email: hps@chinapharmaholdings.com China Pharma Holdings, Inc. Announces Notification of NYSE American Listing Deficiency About China Pharma Holdings, Inc. Based in Haikou, Hainan Province, China, China Pharma H]
CPHI [CHINA PHARMA] 8-K: Contact: China Pharma Holdings, Inc. Ms. Diana Na
[Contact: China Pharma Holdings, Inc. Ms. Diana Na Huang Phone: +86-898-6681-1730 (China) Email: hps@chinapharmaholdings.com China Pharma Holdings, Inc. Announces Notification of NYSE American Listing Deficiency About China Pharma Holdings, Inc. Based in Haikou, Hainan Province, China, China Pharma H]
CPHI [CHINA PHARMA] 10-Q:
[] [CERTIFICATION OF OF THE SARBANES-OXLEY ACT OF 2002 I, Zhilin Li, certify that: 1. I have reviewed this report on Form 10-Q of China Pharma Holdings, Inc.; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to m]
CPHI [CHINA PHARMA] 10-Q: (Original Filing)
[] [CERTIFICATION OF OF THE SARBANES-OXLEY ACT OF 2002 I, Zhilin Li, certify that: 1. I have reviewed this report on Form 10-Q of China Pharma Holdings, Inc.; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to m]
CPHI [CHINA PHARMA] 8-K: (Original Filing)
[Contact: China Pharma Holdings, Inc. Ms. Diana Na Huang Phone: +86-898-6681-1730 (China) Email: hps@chinapharmaholdings.com China Pharma Holdings, Inc. Reports Full Year 2016 Financial Results HAIKOU CITY, China, March 31, 2017 - China Pharma Holdings, Inc. (NYSE MKT: CPHI) (“China Pharma,” the “Com]
CPHI [CHINA PHARMA] 8-K: Contact: China Pharma Holdings, Inc. Ms. Diana Na
[Contact: China Pharma Holdings, Inc. Ms. Diana Na Huang Phone: +86-898-6681-1730 (China) Email: hps@chinapharmaholdings.com China Pharma Holdings, Inc. Reports Full Year 2016 Financial Results HAIKOU CITY, China, March 31, 2017 - China Pharma Holdings, Inc. (NYSE MKT: CPHI) (“China Pharma,” the “Com]
CPHI [CHINA PHARMA] 10-K: (Original Filing)
[] [Loans Extension Confirmation Letter Reference is made to the loans from Ms. Heung Mei Tsui to China Pharma Holdings, Inc. (the “Company”), the principal and accumulated interest totaled USD1,354,567 and USD71,303.91 respectively as of December 31, 2016. Due to the fact the Company temporarily did]
CPHI [CHINA PHARMA] 10-K:
[] [Loans Extension Confirmation Letter Reference is made to the loans from Ms. Heung Mei Tsui to China Pharma Holdings, Inc. (the “Company”), the principal and accumulated interest totaled USD1,354,567 and USD71,303.91 respectively as of December 31, 2016. Due to the fact the Company temporarily did]
